Although cholesterol is an essential compound of our body, involved in all cells’ structure and precursor of steroid hormones, it can become harmful when present in too high levels in the blood. Accumulation of cholesterol in the walls of arteries, mainly the heart arteries, promotes the formation of fat plaques, eventually leading to atherosclerosis and heart diseases such as stroke.
The cholesterol used in the body (70% produced by the liver and 30% coming for the diet) travels via the bloodstream to where it is needed in the body through special transport proteins. When cholesterol is traveling with a protein, it is called a lipoprotein. Lipoproteins exist in different forms, LDLs (Low Density Lipoproteins) and HDLs (High Density Lipoproteins) being the best known.
So far, the theory assumed that LDL delivered cholesterol to cells, and thus was called « bad cholesterol », whereas HDL was thought to remove excess cholesterol by transporting it, via the bloodstream, to the liver in order to be excreted, therefore named « good cholesterol ». Hepatic production of bile acids accounts for the majority of cholesterol breakdown. This path of excess cholesterol elimination is particularly important in situations of massive cholesterol ingestion. This resulted in the common thought that HDLs are good to have around and that a healthy person will have high levels of HDL (good cholesterol) and low levels of LDL (bad cholesterol). High levels of LDL are thus commonly associated with coronary atherosclerosis, and high levels of HDL with protection against cardiovascular diseases.
Brand new findings from a study (1) published last May, which makes use of powerful database of genetic information and relies on quick and low-cost genetic analysis, suggest that there is no causative relationship between higher good cholesterol levels and lower heart disease risk. The study showed that people with inherited genes that provide them with naturally higher HDL levels were not better protected against heart disease that those with genes giving them slightly lower HDL levels. For comparison, the researchers also examined genetic variations altering LDL levels. In that case, the results clearly showed effects on the risk.
These findings are quite disturbing taking into consideration all the companies developing and testing drugs aiming at rising HDL levels and the frequent recommendations to patients with low HDL levels to raise them by taking niacin. Thus, without questioning the already existing well-documented studies leading to an association between higher good cholesterol levels and lower heart disease risk, this new study challenges the causative nature of this link.
What if higher HDL was just a sign that something else is going on that reduces the risk? Let’s imagine two species of sheep corresponding to, respectively, good and bad cholesterol: white sheep eating merely grass and brown ones preferentially eating flowers. As expected, you will find more flowers on a field with white sheep than on a field occupied by brown sheep. It’s also pretty clear that putting more brown sheep (LDL) onto the field will lead to the disappearance of the flowers (lower protection against risk). However, putting more white sheep (HDL) onto the field will not make more flowers grow (increased protection). Still, for a person walking nearby, the presence of white sheep onto a field will indicated that a lot of flowers can be found there.
Within the scientific community, reactions differ. Some researchers think the study is striking enough to invite us to go back to basic laboratory experiments on HDL before blindly going on with the common « HDL hypothesis », whereas others remain optimistic and suggest the protecting effect of higher HDL levels could be due to some specific types of HDL or to more pronounced level differences that the ones triggered by genetic variations.
1. Voight, B. F., et al. (2012). Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet